Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973-2011.

Journal of cancer research and clinical oncology - 1 Dec 2015

Deadmond Melissa A, Smith-Gagen Julie A

Abstract excerpt

PURPOSE: Recent diagnostic and cancer reporting changes influencing myeloproliferative neoplasms (MPNs) encourage the assessment of trends and examination of the recently identified MPN subtypes: polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), across the age continuum by race and ethnicity. METHODS: Surveillance, Epidemiology, and End Results data provided MPN incidence...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Incidence
Share to Janus Kinase 2
Share to Myeloproliferative Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Staging

Share to Polycythemia Vera

Share to Primary Myelofibrosis

Share to SEER Program

Share to Thrombocythemia, Essential

Source

Identifiers

PMID: 25968903
DOI: 10.1007/s00432-015-1983-5

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973-2011.PMID 25968903Read ↗

Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis.Semantic proximity Read ↗

Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger.Semantic proximity Read ↗

Topics of Interest in Women With Myeloproliferative Neoplasms.Semantic proximity Read ↗

Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms.Semantic proximity Read ↗

Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

Update from the latest WHO classification of MPNs: a user's manual.Semantic proximity Read ↗

Clonal Hematopoiesis and Mutations of Myeloproliferative NeoplasmsSemantic proximity Read ↗

Classification, Diagnosis and Management of Myeloproliferative Disorders in the JAK2V617F EraSemantic proximity Read ↗

Myeloproliferative and lymphoproliferative disorders: State of the art.Semantic proximity Read ↗

Next-Generation Sequencing Mutational Landscape and Clinical Features of Chinese Adults with Myeloproliferative NeoplasmsSemantic proximity Read ↗

From essential thrombocythemia to polycythemia vera (ET-2-PV): rationale and design of a multicenter ELN study.Semantic proximity Read ↗

The 2008 World Health Organization classification system for myeloproliferative neoplasmsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.